Catalyst 2024: advancing global health priorities
Menstrual cups are safe and sustainable – but they can be tricky for first-time users, our new study shows
Advancing research through NHMRC grants and scholarships
2024 in review: July to December
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Towards a cure for long COVID: the strengthening case for persistently replicati...
Exploring the Feasibility and Acceptability of Technological Interventions to Pr...
A systematic review and meta-analysis of heat exposure impacts on maternal, feta...
The role and value of counsellors in the treatment journeys of people with tuber...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Appeals
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Burnet Institute is developing biologic and small molecule therapeutics that have potential application in women's health, infectious disease & immunological conditions.
Find us at BIO 2024 this June.
In collaboration with Monash Institute of Pharmaceutical Sciences (MIPS), we are developing next-gen...
A small molecule therapeutic to potentially combat a variety of conditions affecting women’s sexual ...
A potentially broad spectrum Fc-fusion protein to treat SARS-CoV-2, comprising ACE2 (SARS-CoV-2 rece...
